EPISODE · Apr 23, 2026 · 8 MIN
CAPM's Corporate Corruption: The Theory That Runs Wall Street and Gets Applied Wrong to Your Business
from The Stagnation Assassin Show · host Todd Hagopian
Send us Fan MailYour finance team set the hurdle rate for capital projects using CAPM. They pulled beta from historical stock prices. They used the 10-year Treasury as the risk-free rate. They added a market risk premium from a Damodaran database. They produced a precise discount rate to four decimal places. And then they used that discount rate — built for valuing public equity — to evaluate a capital project in a private manufacturing division that has nothing to do with stock price volatility. The tool was right. The application was wrong. And bad hurdle rates produce bad capital allocation — systematically, quietly, year after year. Today we fix the application.In this episode, Todd Hagopian — the original Stagnation Assassin — goes deep on the Capital Asset Pricing Model: what Sharpe, Lintner, and Mossin actually built, what CAPM legitimately contributes to operator thinking, where it breaks down the moment it leaves the world of public securities, and what operators must do differently when their finance team hands over a single corporate WACC and expects it to work for every project on the list.Todd breaks down CAPM's most useful contributions — the systematic-vs-idiosyncratic risk distinction and the structured framework for cost of equity — the three ways the model fails operating companies, and two corrections that turn a misapplied discount rate into a useful capital allocation tool.Key topics covered:The origins of CAPM — Sharpe (1964), Lintner (1965), and Mossin (1966), building on Markowitz's portfolio theory, and Sharpe's 1990 Nobel Prize — and why understanding the model's original purpose is the key to knowing where it appliesThe formula and what it means: Expected Return = Risk-Free Rate + Beta × (Market Return − Risk-Free Rate), and how beta measures sensitivity to market movementsSystematic risk vs. idiosyncratic risk — why investors should only be compensated for risk that cannot be diversified away, and why this distinction remains correct and operationally valuable even when the rest of the model failsWhy CAPM provides a legitimate starting point for cost of equity estimation in WACC construction — the inputs require judgment, but the framework at least makes the judgments explicit and challengeableThe beta problem — why historical stock price volatility is a poor proxy for the actual risk of a specific capital project, and why a chemical plant expansion's real risks (construction overrun, permitting, technical performance, demand) are invisible to the company's stock tickerThe single-discount-rate error — why using a 10% corporate WACC as the hurdle rate for both a low-risk capacity expansion and a high-risk new market entry is conceptually wrong, and why most companies do it anyway because it's administratively easierProject-specific risk adjustments — adding a premium to the base WACC for new markets, new technologies, and new customer segments, and subtracting for contractually secured returnsThe counterintuitive truth: a single hurdle rate for every project is a uniform hammer applied to every nail. Some of your projects are nails. Some are bolts. Some are screws. The tool that works for one destroys the others — and a four-decimal-place discount rate that's precisely wrong for three out of five projects will, over time, quietly misallocate more capital than any single bad investment decision ever could.Grab Todd's book "The Unfair Advantage: Weaponizing the Hypomanic Toolbox" at https://www.amazon.com/dp/B0FV6QMWBX📖 Stagnation Assassin (Todd's Second Book) — https://www.amazon.com/Stagnation-Assassin-Anti-Consultant-Todd-Hagopian/dp/B0GV1KXJFNVisit the world's largest stagnation slaughterhouse at StagnationAssassins.comThe Stagnation Assassin Show | Todd Hagopian | 6-minut
NOW PLAYING
CAPM's Corporate Corruption: The Theory That Runs Wall Street and Gets Applied Wrong to Your Business
No transcript for this episode yet
Similar Episodes
No similar episodes found.